{"name":"3B Pharmaceuticals GmbH","slug":"3b-pharmaceuticals-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxQTlZxRFFXLVo0YjJSY0FvdzdtVW9xdmJvNjlWSi1vZnBNbmF4OFp1ZzNvaVd1NEl4aDZkcjV1dHMzaTQwMUxlTm01MEdyV1JDWFVybmlRdmtZVWc5X3FhUUVGMzA0VkJuTWJIaC1KSUY3VG1zblRXdlJ3Y3VLM2I5ZjJWZGxkQ18tYlJhNy04ZkFIZTgxejRMU25yWW8xTzJSaTVGZ2Z1cW85ZE5YLWJjTXI2cUN1Z1BhTzUwS2NuNnlxSkFsTVowRldpRy01UG41TUxqb2d4d0o5V2xwWDJHblFtekMtX0t3VUFnbmNyUW14WkNZdTY2RlpNbXBtaWJrMnpkSHdaMmdsblZPVTJVMXVTZ0xBYkJOdm56V1ZIclBueURDY2tjejU5RmxsMmM?oc=5","date":"2024-11-14","type":"deal","source":"PR Newswire","summary":"ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors - PR Newswire","headline":"ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radiol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWThuaUNud21xd2tGX3BlaTE2MkxZWTBZdTZNZ1BVM0dPdUVkMWdnX2h0ODFYSUY1TlN6YUtiNGRaSllGUnlxelNMY2JCOU5Pa3R5YlY2MGstdDAxRE85d21pVVdnNF91eHp4dHBCcWVtTTR3VDZWZ0syYXlvdGVWczRPeTJwQ0dpM2w4UHh1RnIyRVBENEpuWE5zazZ6ZTQ1S1E?oc=5","date":"2023-04-25","type":"deal","source":"European Biotechnology Magazine","summary":"Novartis in US$465m deal with 3B Pharmaceuticals GmbH - European Biotechnology Magazine","headline":"Novartis in US$465m deal with 3B Pharmaceuticals GmbH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOcnRCSm95Sll1Z0p6bkVnNjZCZE5tLXd0S1R1VUlzbFNwbVZUTVZSTzBROGJkTlZCSEtSREJVWHhsVDJGSmdRYlRab1BoRUpKelU1X0ZycmpabmlUUVFnSDZNdjFmSnBUWlM5V0luNGJSUGRyWmI0dUhxU0VTbVFyd2hReXJUUUNNZ2lxc2tOMHk0Wm0yTFE1clhxcmljNldUSGtvVkpwVEpNS050eG1pcVZyZzFDdw?oc=5","date":"2023-04-24","type":"deal","source":"Fierce Biotech","summary":"Novartis pens $425M biobucks deal with German biotech, scooping up more radiopharmaceutical tech - Fierce Biotech","headline":"Novartis pens $425M biobucks deal with German biotech, scooping up more radiopharmaceutical tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNV2NwemtFYVctR21RNzVqcWtpRWVWc24zaHdRdDJIb3E3MjRLbVhfdXZaaGtQbFhZVlJoU2ZtdnJ2QUlQamxWNzk5QTZBYlJFazJrak1ud1ZMdU1aRFZNbjFMbl94OXFmQ3lyYWY3TWRrWVhPRHBsaWdHcDF4M0lLWlc1ZjB6Wkh2R1ZNYmowWEgxNENlZGdVOVQ3eDA2Z0toa05RbVR6VHdzbVJDaGkzT0wtUQ?oc=5","date":"2023-04-24","type":"deal","source":"Medical Marketing and Media","summary":"Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology - Medical Marketing and Media","headline":"Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxObkFMMTJiOURTMWxXMEdxVm9HNUxSTm9tVmZYU2h4d0VBTGE3V1NfMVU5Y2JOZVVEcmlvdDdfcHBJM2dQXzA1enBSblVxa1c2dng1eG4xb0ZWcUtPek9jaGVOMmRWeGtKZFFVQndoSW1mb0MydTRPU0dJbkhiWElRTkdfVG5MZGRORzFDUnpMZmNaaGN6NHNIT0lhdXhkNzhsamJNaUJ3Vlo3NzItUVE?oc=5","date":"2016-11-09","type":"pipeline","source":"News-Medical","summary":"Novel purification process for camelid heavy chain antibodies - News-Medical","headline":"Novel purification process for camelid heavy chain antibodies - News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}